(Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | (Q6)Sep 30, 2019 | (FY)Mar 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 61.60%-43.68M | ---- | -524.74%-113.73M | ---- | 55.17%-18.2M | ---- | -119.98%-40.6M | ---- | 136.98%203.2M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | 70.13%-190K | ---- | -66.49%-636K | ---- | 83.72%-382K | ---- | 19.95%-2.35M | ---- | -189.72%-2.93M |
Attributable subsidiary (profit) loss | ---- | 207.65%2.86M | ---- | 5.94%928K | ---- | 7,200.00%876K | ---- | 102.48%12K | ---- | -147.68%-483K |
Impairment and provisions: | --0 | -91.08%8.08M | --0 | 1,542.84%90.57M | --0 | --5.51M | --0 | --0 | --0 | -90.20%40.36M |
-Impairmen of inventory (reversal) | ---- | ---- | ---- | ---277K | ---- | ---- | ---- | ---- | ---- | 213.26%5.08M |
-Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -88.89%15M |
-Other impairments and provisions | ---- | -91.10%8.08M | ---- | 1,547.87%90.85M | ---- | --5.51M | ---- | ---- | ---- | -92.29%20.28M |
Revaluation surplus: | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Asset sale loss (gain): | --0 | ---1.75M | --0 | --0 | --0 | --0 | --0 | -60.15%2.51M | --0 | 1,398.56%6.3M |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -75.32%2.48M | ---- | --10.07M |
-Loss (gain) on sale of property, machinery and equipment | ---- | ---1.75M | ---- | ---- | ---- | ---- | ---- | 100.69%26K | ---- | -676.91%-3.77M |
Depreciation and amortization: | --0 | 5.65%10.84M | --0 | -9.84%10.26M | --0 | -27.62%11.38M | --0 | -22.75%15.72M | --0 | -57.75%20.35M |
-Depreciation | ---- | 5.76%10.84M | ---- | 53.01%10.25M | ---- | -16.77%6.7M | ---- | -25.88%8.05M | ---- | -11.59%10.86M |
-Amortization of intangible assets | ---- | ---- | ---- | -99.79%10K | ---- | -38.99%4.68M | ---- | -17.35%7.67M | ---- | -73.98%9.28M |
-Other depreciation and amortization | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 1.96%208K |
Financial expense | ---- | -8.97%3.78M | ---- | 8.34%4.16M | ---- | -40.46%3.84M | ---- | -66.33%6.44M | ---- | -34.99%19.14M |
Special items | ---- | 1,150.00%300K | ---- | 100.73%24K | ---- | -38.84%-3.31M | ---- | 99.36%-2.38M | ---- | -1,721.62%-372.45M |
Operating profit before the change of operating capital | --0 | -134.48%-19.76M | --0 | -2,805.17%-8.43M | --0 | 98.60%-290K | --0 | 76.14%-20.65M | --0 | -6.77%-86.51M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 204.90%2.76M | ---- | 57.50%-2.63M | ---- | 36.49%-6.2M | ---- | -505.21%-9.76M | ---- | 78.19%-1.61M |
Accounts receivable (increase)decrease | ---- | -10.65%-7.75M | ---- | 64.31%-7M | ---- | -303.17%-19.62M | ---- | -87.61%9.66M | ---- | 7.23%77.94M |
Accounts payable increase (decrease) | ---- | 1,224.33%27.55M | ---- | -81.16%2.08M | ---- | 252.64%11.04M | ---- | 74.31%-7.23M | ---- | -314.68%-28.16M |
Cash from business operations | --0 | 64.58%-2.71M | --0 | 0.89%-7.66M | --0 | 56.72%-7.73M | --0 | 53.45%-17.85M | --0 | -1,362.03%-38.35M |
China income tax paid | ---- | 91.11%-4K | ---- | ---45K | ---- | ---- | ---- | -35.71%-19K | ---- | 99.49%-14K |
Special items of business | ---- | -166.25%-5.52M | ---- | 13.39%8.33M | ---- | -27.50%7.34M | ---- | --10.13M | ---- | ---- |
Net cash from operations | -271.39%-22.83M | 64.74%-2.72M | -284.96%-6.15M | 0.31%-7.7M | 156.84%3.32M | 56.76%-7.73M | -194.02%-5.85M | 53.42%-17.87M | 3.89%6.22M | -612.40%-38.36M |
Cash flow from investment activities | ||||||||||
Interest received - investment | -57.14%21K | -70.13%190K | 308.33%49K | 66.49%636K | -99.41%12K | -86.60%382K | 28,985.71%2.04M | 37.86%2.85M | -98.60%7K | 104.35%2.07M |
Loan receivable (increase) decrease | -112.29%-1.5M | 109.86%1.59M | 172.03%12.21M | -146.61%-16.14M | -144.02%-16.95M | 2,834.07%34.62M | --38.5M | 103.37%1.18M | ---- | ---35M |
Sale of fixed assets | ---- | 365.09%5.1M | --5.05M | --1.1M | ---- | ---- | ---- | 78.62%518K | ---- | -47.08%290K |
Purchase of fixed assets | 91.71%-18K | 97.92%-223K | 97.97%-217K | -375.43%-10.7M | -380.75%-10.69M | -16.15%-2.25M | -24.40%-2.22M | -58.85%-1.94M | -85.76%-1.79M | 81.51%-1.22M |
Purchase of intangible assets | ---- | ---- | ---- | ---- | -140.00%-3M | ---- | ---1.25M | ---- | ---- | ---- |
Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 1,332.24%7.53M | ---171K | ---611K |
Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---440K | ---440K | ---- |
Cash on investment | ---- | ---- | ---- | ---- | ---- | -41,869.06%-58.34M | ---56M | ---139K | ---- | ---- |
Other items in the investment business | ---3K | 23.06%-7.05M | ---- | ---9.16M | --1.03M | ---- | ---- | ---- | 78.42%521K | ---- |
Net cash from investment operations | -108.78%-1.5M | 98.86%-390K | 157.75%17.09M | -33.95%-34.27M | -56.26%-29.59M | -367.59%-25.58M | -912.78%-18.94M | 127.73%9.56M | 93.80%-1.87M | -584.40%-34.47M |
Net cash before financing | -322.34%-24.33M | 92.60%-3.11M | 141.66%10.94M | -26.01%-41.97M | -5.98%-26.27M | -300.94%-33.31M | -669.82%-24.79M | 88.59%-8.31M | 117.99%4.35M | -598.87%-72.84M |
Cash flow from financing activities | ||||||||||
New borrowing | -12.35%19.85M | -13.95%74.34M | -26.64%22.65M | 17.36%86.39M | 19.51%30.87M | -23.06%73.61M | -46.30%25.83M | -43.10%95.67M | -6.26%48.1M | 43.56%168.15M |
Refund | 15.69%-22.25M | 8.57%-78.61M | 14.50%-26.39M | -13.40%-85.97M | -1.85%-30.87M | 40.78%-75.81M | 41.15%-30.31M | 44.22%-128.03M | 61.10%-51.5M | -91.96%-229.54M |
Issuing shares | --42.26M | -77.64%12.3M | ---- | --55M | --40.5M | ---- | ---- | 7.18%86M | ---- | 301.21%80.24M |
Interest paid - financing | 20.95%-1.57M | 8.62%-3.47M | 1.64%-1.98M | -7.78%-3.79M | -13.40%-2.01M | 45.38%-3.52M | 60.00%-1.78M | 45.73%-6.44M | 62.02%-4.44M | -158.61%-11.87M |
Issuance expenses and redemption of securities expenses | ---360K | 72.73%-246K | ---- | ---902K | ---612K | ---- | ---- | -12.50%-54K | ---- | ---48K |
Other items of the financing business | 13.50%-2.53M | -41.03%-7.15M | -56.94%-2.93M | -48.43%-5.07M | -40.75%-1.87M | -19.78%-3.42M | 32.33%-1.33M | -104.07%-2.85M | -102.74%-1.96M | 573.57%70.05M |
Net cash from financing operations | 509.04%35.4M | -106.21%-2.83M | -124.04%-8.66M | 599.72%45.65M | 575.12%36.01M | -120.63%-9.14M | 22.70%-7.58M | -42.46%44.29M | -116.65%-9.81M | 4,303.88%76.97M |
Effect of rate | -5.89%-593K | 93.01%276K | ---560K | -55.45%143K | ---- | 218.01%321K | 122.68%61K | 34.46%-272K | 78.68%-269K | -136.44%-415K |
Net Cash | 383.57%11.07M | -261.37%-5.94M | -76.50%2.29M | 108.67%3.68M | 130.09%9.74M | -217.96%-42.45M | -493.33%-32.37M | 769.78%35.98M | -115.72%-5.46M | 133.76%4.14M |
Begining period cash | -70.72%2.35M | 91.37%8.01M | 91.37%8.01M | -90.96%4.19M | -90.96%4.19M | 336.93%46.31M | 336.93%46.31M | 54.12%10.6M | 54.12%10.6M | -61.78%6.88M |
Cash at the end | 31.66%12.82M | -70.72%2.35M | -30.06%9.74M | 91.37%8.01M | -0.58%13.92M | -90.96%4.19M | 187.28%14.01M | 336.93%46.31M | -87.91%4.88M | 54.12%10.6M |
Cash balance analysis | ||||||||||
Cash and cash equivalent balance | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Guowei Certified Public Accountants Co., Ltd. | -- | Guowei Certified Public Accountants Co., Ltd. | -- | Guowei Certified Public Accountants Co., Ltd. | -- | Guowei Certified Public Accountants Co., Ltd. | -- | Guowei Certified Public Accountants Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data